Medical Gas Market Size was valued at USD 14.16 Billion in 2023 and is expected to reach USD 28.25 billion by 2032, growing at a CAGR of 8.0% over the forecast period 2024-2032.
This report provides key statistical insights and emerging trends in the Medical Gas Market, focusing on clinical demand and infrastructure developments. It analyses the incidence and prevalence of respiratory and surgical conditions driving usage, regional volume trends, and prescription patterns across healthcare settings. The report also studies the volumes of healthcare spending on medical gas systems, production and supply chain metrics, and compliance with the global regulatory frameworks. Such insights allow stakeholders to gain a better understanding of usage dynamics, investment patterns, and emerging safety standards in the sector. This data is segregated by regions and funding sources, providing a detailed perspective on demand-side and operational developments influencing the market's future for medical gasses. These factors can be attributed to the rising prevalence of chronic respiratory disorders, a growing geriatric population, and measures taken by the authorities to promote healthcare infrastructure.
The World Health Organization (WHO) states that chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality with an estimated 64 million affected people worldwide and that the condition is projected to be among the three leading causes of death by 2031. The prevalence of chronic obstructive pulmonary disease (COPD) among adults in the U.S. was 4.3% in 2023, according to data from the National Center for Health Statistics. In 2023, North America (U.S.) accounted for a dominant share of the medical gas market due to developed health infrastructure and an increase in demand for home healthcare solutions. In the U.S., the medical gas market has shown consistent growth from USD 3.82 billion in 2023 to USD 7.55 billion in 2032. Based on the above-mentioned factors, the market is expected to grow at a CAGR of 7.88% and exhibits a trend of increasing demand due to respiratory chronic diseases, surgical procedures, and a growing geriatric population. The continued investments in healthcare infrastructure and home-based oxygen therapies will also sustain this upward trajectory.
Drivers
Increasing surgical procedures worldwide are accelerating the usage of anesthetic and respiratory medical gases in clinical environments.
Increasing global surgical procedures such as elective, emergency, and outpatient surgeries have phenomenally increased the usage of medical gases in hospitals and surgical centers. Anesthetic gases such as nitrous oxide and oxygen are crucial during operations for pain management and patient stability. As surgical procedures become increasingly minimally invasive, and more robotic-assisted surgeries become commonplace, the need for accurate and reliable gas delivery systems continues to increase as well. Rising healthcare spending, better surgery results, and development in anesthesia techniques support this trend. The increasing prevalence of trauma, cancer, cardiovascular diseases, and orthopedic diseases are other factors aiding to rise in surgeries and subsequently medical gas demand. Medical gas consumption has also risen in developing regions, where governments and private healthcare providers are upgrading operating rooms and increasing surgical capacity. Furthermore, the usage of these gases increases as the aged population doubles, requiring more complex treatments like joint replacements and cardiac surgeries. Training of surgical personnel and deployment of mobile surgical units in rural areas is also impacting the demand. The above all points together boost the market's growth by leveraging surgical care on regularized usage of medicated gases.
Restrain
The high cost of infrastructure development and maintenance for medical gas systems affects accessibility in developing healthcare facilities.
High capital investment is associated with the installation and maintenance of medical gas components especially in small- and mid-sized healthcare environments or in rural hospitals. The price tag is significant from installing pipelining, gas generation, and backup cylinders to leak-proof delivery and safe storage. Regular maintenance, staff training, compliance testing, and emergency backup create ongoing costs. In developing economies, where budget limits the expansion of advanced healthcare services, this becomes a serious deterrent. This is to say that major hospitals might settle for more affordable options or postpone infrastructure modernization, ultimately limiting the availability of quality gas-based therapy. Poor maintenance and technical deficiencies may also lead to operational failures that interrupt care delivery and compromise patient safety. In rural areas, the unavailability of trained staff and erratic electricity supply for plants generating gas have hit it the hardest. When such infrastructure is available, scalability problem arises when patient volume increases, thus creating inefficiencies and potential dangers. This is especially the case for homecare oxygen therapy program implementation. The investment and the responsibility to have reliable medical gas systems is a continuous roadblock to market penetration, particularly across low-resource and underserved demographics.
Opportunities
Rising investments in healthcare infrastructure and modernization of hospitals across emerging economies are driving global market opportunities.
Governments and private investors are increasingly allocating resources to upgrade healthcare infrastructure, particularly in developing nations across Asia, Africa, and Latin America. This includes building new hospitals, expanding critical care units, and modernizing surgical and emergency facilities all of which depend heavily on reliable medical gas systems. As urbanization increases and healthcare coverage expands under public and private health schemes, the need for oxygen, nitrous oxide, and other gases grows. Multinational corporations are also partnering with local providers to establish manufacturing and distribution centers, enhancing regional availability. Furthermore, global health programs and aid organizations are funding oxygen supply chains and training personnel to manage gas systems effectively. Modernization efforts include integrating automated gas monitoring systems and centralized pipeline networks, boosting efficiency and safety. The push toward digital health also complements these developments, enabling remote supervision and diagnostics. These expansions provide lucrative openings for gas manufacturers, equipment suppliers, and service providers to tap into previously underserved markets. With ongoing healthcare reform and policy support, infrastructure development represents a sustained and promising opportunity for medical gas market players.
Challenges
Limited skilled workforce for handling, monitoring, and maintaining medical gas systems leads to inefficiencies and safety concerns in healthcare delivery.
The shortage of trained professionals capable of safely operating and maintaining medical gas systems is a pressing challenge in both developed and developing healthcare settings. Handling pressurized gases, ensuring proper flow rates, monitoring purity levels, and maintaining delivery systems require specialized skills and certifications. However, many facilities, especially in rural and under-resourced regions, lack adequately trained biomedical engineers, technicians, or clinical staff familiar with medical gas protocols. Improper installation or maintenance can lead to gas leaks, contamination, equipment failure, and even patient harm. Furthermore, regulatory audits often uncover deficiencies in documentation, training records, or standard operating procedures. High staff turnover and limited training programs further aggravate the issue. In fast-growing economies, rapid hospital expansion often outpaces the availability of skilled personnel to manage technical systems like gas pipelines and monitoring units. To mitigate this challenge, industry stakeholders must invest in training modules, certification programs, and remote support solutions. Still, building a well-trained workforce at scale remains difficult, creating a long-term bottleneck that affects both service quality and market reliability in the medical gas sector.
By Product
In 2023, the pure gases segment held the highest share in the medical gas market, accounting for over 57% revenue share. This dominance is attributed to their indispensable role in various medical applications, including respiratory therapy, anesthesia, and diagnostic procedures. The most common pure gas, oxygen is vital for the treatment of chronic lung diseases, such as COPD and asthma, which require continuous ministration. Globally, more than 64 million people suffer from COPD, according to WHO data, and oxygen therapy is a cornerstone of its management. Nitrous oxide is another critical pure gas used in anesthesia during surgical procedures.
Technological advancements in medical equipment further contribute to the growth of this segment. Devices like ventilators and anesthesia machines require pure gases for optimal functionality, ensuring precision and reliability during treatments. An increasing number of surgeries being done wish it be minimally invasive procedures worldwide has led to the increased demand for pure gases because of their ability to create controlled environments. The quality, purity, and safety of plain gases for use in healthcare are governed by regulatory systems. For example, medical oxygen is governed by the FDA and due diligence regarding production practices. The increasing adoption of home healthcare solutions has also fuelled demand for portable oxygen concentrators and other delivery systems that use pure gases.
By Application
In 2023, the therapeutic application segment accounted for 39% of the revenue share owing to broad application for chronic respiratory diseases and critical care procedures. Medicinals such as oxygen are essential for the treatment of disorders like compound obstructive pulmonary illness (COPD) and asthma. Therapeutic gases represent key components in healthcare, as WHO statistics show that respiratory diseases are responsible for metastatically accounting for more than 3 million deaths worldwide annually. Therapeutic gases are extensively utilized in emergency care settings to provide critical care for patients in acute medical emergencies such as cardiac arrest or trauma. Oxygen therapy is frequently the first-line therapy for hypoxemia (decreased blood oxygen levels), rendering it critical in emergency departments and ICUs. Additionally, nitrous oxide acts as an analgesic and anesthetic in the surgical setting. Demand for therapeutic gases has received a major boost from the increasing trend toward home healthcare. Portable oxygen therapy helps to facilitate home treatment for patients with chronic respiratory conditions. This shift aligns with the increasing prevalence of aging populations globally, who often require long-term respiratory support.
By End Use
Hospitals accounted for a significant revenue share of 27% in 2023 due to their extensive use of medical gases across various departments such as ICUs, operating rooms, and emergency care units. Medical gases such as oxygen and nitrous oxide are essential in critical care environments wherein patients may need urgent respiratory assistance or anesthesia for surgeries. The increase in elective surgeries globally has further increased the demand for anesthetic gases that are used broadly in hospitals operating rooms. By 2023, more than 15 million surgeries were being performed each year according to government data from the U.S., many of which required controlled gas environments enabled by the hospitals’ highly advanced infrastructure. Governments are investing in developing healthcare infrastructure around the world, which also gives hospitals a boost. For example, the Indian National Health Mission (NHM) has made provisions for a considerable amount of funding to improve hospital facilities as part of sustainable projects, especially those with advanced medical gas systems. Likewise, European nations have committed large budgets to refurbishing hospital ICUs with high-efficiency ventilators requiring exact gas mixtures. The increased sophistication in the technology-enabled hospitals to be able to use medical gases more efficiently. For example, modern ventilators and anesthesia machines rely on automated systems that ensure precise delivery of oxygen or nitrous oxide during treatments.
In 2023, North America accounted for more than 37% revenue share of the global medical gas market, attributable to advanced healthcare systems and the high prevalence of chronic diseases such as COPD, asthma, and pneumonia in Western countries. This region is a big contributor and the U.S. has solid government initiatives to improve healthcare infrastructure. For example, the FDA oversees manufacturing standards for medical gases, such as oxygen and nitrous oxide, used throughout hospitals and homecare environments. An aging population in the region also fuels the demand for therapeutic gases as of 2023, Census Bureau stats indicated nearly 16% of the U.S. population was aged 65 or older. This demographic transition has contributed to the increasing incidence of age-related respiratory pathology that requires long-term oxygen therapy.
Asia-Pacific is anticipated to grow with the fastest CAGR growth, due to developing health care infrastructure and growing population rates. Countries such as China contribute a large share of global COPD cases approximately 100 million patients necessitating higher demand for oxygen therapy solutions. Government initiatives like India’s Ayushman Bharat scheme have greatly increased the delivery of affordable healthcare services therapeutic gas delivery systems included. Rapid urbanization across Asia-Pacific adds to this by increasing the burden of pollution-related respiratory disorders, including asthma, in the urban population. Additionally, investments in hospital infrastructure across developing economies have boosted adoption rates of advanced medical equipment reliant on pure gases.
Air Liquide (ALPHAGAZ, MEDIGAS)
Linde plc (LOX, HiQ Specialty Gases)
Praxair Technology, Inc. (now part of Linde) (Heliox, Medipure)
Air Products and Chemicals, Inc. (Freshline gases, MEDIGAS)
Taiyo Nippon Sanso Corporation (MediOX, Sanarc)
Atlas Copco AB (GA Medical Compressors, BeaconMedaes)
SOL Group (SOL OXYGENE MEDICAL, NITROX SOL)
GCE Group (Mediline, MediSelect II)
Amico Corporation (Amico Medical Gas Outlets, Alert-3 Alarm Panels)
Matheson Tri-Gas, Inc. (Medical Oxygen USP, Nitrous Oxide USP)
Key Users
Mayo Clinic
Cleveland Clinic
Johns Hopkins Hospital
Mount Sinai Health System
Apollo Hospitals (India)
Bumrungrad International Hospital (Thailand)
NHS (United Kingdom)
Kaiser Permanente
Fortis Healthcare
HCA Healthcare
In January 2025, Atlas Copco Group acquired Medi-Teknique Ltd., significantly increasing its market presence in medical gas maintenance services throughout the UK.
In October 2023, Air Liquide introduced advances in portable oxygen concentrators aimed at extending home healthcare solutions worldwide.
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | USD 14.16 Billion |
| Market Size by 2032 | USD 28.25 Billion |
| CAGR | CAGR of 8.0% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product (Pure Gases, Gas Mixtures) • By End Use (Hospitals, Ambulatory Surgical Centers, Home Healthcare, Pharmaceutical And Biotechnology Companies, Diagnostic and Research Laboratories, Academic and Research Institutions) • By Application (Therapeutic, Diagnostic, Pharmaceutical Manufacturing, Others) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles | Air Liquide, Linde plc, Praxair Technology Inc., Air Products and Chemicals Inc., Taiyo Nippon Sanso Corporation, Atlas Copco AB, SOL Group, GCE Group, Amico Corporation, Matheson Tri-Gas Inc. |
Ans. The projected market size for the Medical Gas Market is USD 28.25 billion by 2032.
Ans: The North American region dominated the Medical Gas Market in 2023.
Ans. The CAGR of the Medical Gas Market is 8.0% during the forecast period of 2024-2032.
Ans: Rising investments in healthcare infrastructure and modernization of hospitals across emerging economies are driving global market opportunities.
Ans: The Pure Gases segment dominated the Medical Gas Market.
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence of Respiratory and Surgical Conditions (2023)
5.2 Medical Gas Demand Volume by Region (2020–2032)
5.3 Prescription and Usage Trends of Medical Gases (2023)
5.4 Healthcare Spending on Medical Gas Infrastructure (2023)
5.5 Production and Supply Chain Volume – Medical Gases (2023)
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion plans and new Product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Medical Gas Market Segmentation by Type
7.1 Chapter Overview
7.2 Pure Gases
7.2.1 Pure Gases Market Trends Analysis (2020-2032)
7.2.2 Pure Gases Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.3 Medical Air
7.2.3.1 Medical Air Market Trends Analysis (2020-2032)
7.2.3.2 Medical Air Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.4 Oxygen
7.2.4.1 Oxygen Market Trends Analysis (2020-2032)
7.2.4.2 Oxygen Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.5 Carbon Dioxide
7.2.5.1 Carbon Dioxide Market Trends Analysis (2020-2032)
7.2.5.2 Carbon Dioxide Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.6 Nitrous Oxide
7.2.6.1 Nitrous Oxide Market Trends Analysis (2020-2032)
7.2.6.2 Nitrous Oxide Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.7 Nitrogen
7.2.7.1 Nitrogen Market Trends Analysis (2020-2032)
7.2.7.2 Nitrogen Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.8 Helium
7.2.8.1 Helium Market Trends Analysis (2020-2032)
7.2.8.2 Helium Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Gas Mixtures
7.3.1 Gas Mixtures Market Trends Analysis (2020-2032)
7.3.2 Gas Mixtures Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.3 Aerobic Gas Mixtures
7.3.3.1 Aerobic Gas Mixtures Market Trends Analysis (2020-2032)
7.3.3.2 Aerobic Gas Mixtures Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.4 Anaerobic Gas Mixtures
7.3.4.1 Anaerobic Gas Mixtures Market Trends Analysis (2020-2032)
7.3.4.2 Anaerobic Gas Mixtures Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.5 Medical Laser Mixtures
7.3.5.1 Medical Laser Mixtures Market Trends Analysis (2020-2032)
7.3.5.2 Medical Laser Mixtures Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.6 Blood Gas Mixtures
7.3.6.1 Blood Gas Mixtures Market Trends Analysis (2020-2032)
7.3.6.2 Blood Gas Mixtures Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.7 Lung Diffusion Mixtures
7.3.7.1 Lung Diffusion Mixtures Market Trends Analysis (2020-2032)
7.3.7.2 Lung Diffusion Mixtures Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.8 Medical Drug Gas Mixtures
7.3.8.1 Medical Drug Gas Mixtures Market Trends Analysis (2020-2032)
7.3.8.2 Medical Drug Gas Mixtures Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.9 Other Gas Mixtures
7.3.9.1 Other Gas Mixtures Market Trends Analysis (2020-2032)
7.3.9.2 Other Gas Mixtures Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Medical Gas Market Segmentation By Structure
8.1 Chapter Overview
8.2 Hospitals
8.2.1 Hospitals Market Trend Analysis (2020-2032)
8.2.2 Hospitals Foams Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Ambulatory Surgical Centers
8.3.1 Ambulatory Surgical Centers Market Trends Analysis (2020-2032)
8.3.2 Ambulatory Surgical Centers Market Size Estimates and Forecasts to 2032 (USD Billion)
8.4 Home Healthcare
8.4.1 Home Healthcare Market Trends Analysis (2020-2032)
8.4.2 Home Healthcare Market Size Estimates and Forecasts to 2032 (USD Billion)
8.5 Pharmaceutical And Biotechnology Companies
8.5.1 Pharmaceutical And Biotechnology Companies Market Trends Analysis (2020-2032)
8.5.2 Pharmaceutical And Biotechnology Companies Market Size Estimates and Forecasts to 2032 (USD Billion)
8.6 Diagnostic and Research Laboratories
8.6.1 Diagnostic and Research Laboratories Market Trends Analysis (2020-2032)
8.6.2 Diagnostic and Research Laboratories Market Size Estimates and Forecasts to 2032 (USD Billion)
8.6 Academic and Research Institutions
8.6.1 Academic and Research Institutions Market Trends Analysis (2020-2032)
8.6.2 Academic and Research Institutions Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Medical Gas Market Segmentation By End-Use
9.1 Chapter Overview
9.2 Therapeutic
9.2.1 Therapeutic Market Trends Analysis (2020-2032)
9.2.2 Therapeutic Market Size Estimates and Forecasts to 2032 (USD Billion)
9.3 Diagnostic
9.3.1 Diagnostic Market Trends Analysis (2020-2032)
9.3.2 Diagnostic Market Size Estimates and Forecasts to 2032 (USD Billion)
9.4 Personal Care & Cosmetics
9.4.1 Personal Care & Cosmetics Market Trends Analysis (2020-2032)
9.4.2 Personal Care & Cosmetics Market Size Estimates and Forecasts to 2032 (USD Billion)
9.5 Pharmaceutical Manufacturing
9.5.1 Pharmaceutical Manufacturing Market Trends Analysis (2020-2032)
9.5.2 Pharmaceutical Manufacturing Market Size Estimates and Forecasts to 2032 (USD Billion)
9.6 Others
9.6.1 Others Market Trends Analysis (2020-2032)
9.6.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
10. Regional Analysis
10.1 Chapter Overview
10.2 North America
10.2.1 Trends Analysis
10.2.2 North America Medical Gas Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.2.3 North America Medical Gas Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.2.4 North America Medical Gas Market Estimates and Forecasts, By Structure (2020-2032) (USD Billion)
10.2.5 North America Medical Gas Market Estimates and Forecasts, By End-Use (2020-2032) (USD Billion)
10.2.6 USA
10.2.6.1 USA Medical Gas Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.2.6.2 USA Medical Gas Market Estimates and Forecasts, By Structure (2020-2032) (USD Billion)
10.2.6.3 USA Medical Gas Market Estimates and Forecasts, By End-Use (2020-2032) (USD Billion)
10.2.7 Canada
10.2.7.1 Canada Medical Gas Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.2.7.2 Canada Medical Gas Market Estimates and Forecasts, By Structure (2020-2032) (USD Billion)
10.2.7.3 Canada Medical Gas Market Estimates and Forecasts, By End-Use (2020-2032) (USD Billion)
10.2.8 Mexico
10.2.8.1 Mexico Medical Gas Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.2.8.2 Mexico Medical Gas Market Estimates and Forecasts, By Structure (2020-2032) (USD Billion)
10.2.8.3 Mexico Medical Gas Market Estimates and Forecasts, By End-Use (2020-2032) (USD Billion)
10.3 Europe
10.3.1 Eastern Europe
10.3.1.1 Trends Analysis
10.3.1.2 Eastern Europe Medical Gas Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.3.1.3 Eastern Europe Medical Gas Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.4 Eastern Europe Medical Gas Market Estimates and Forecasts, By Structure (2020-2032) (USD Billion)
10.3.1.5 Eastern Europe Medical Gas Market Estimates and Forecasts, By End-Use (2020-2032) (USD Billion)
10.3.1.6 Poland
10.3.1.6.1 Poland Medical Gas Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.6.2 Poland Medical Gas Market Estimates and Forecasts, By Structure (2020-2032) (USD Billion)
10.3.1.6.3 Poland Medical Gas Market Estimates and Forecasts, By End-Use (2020-2032) (USD Billion)
10.3.1.7 Romania
10.3.1.7.1 Romania Medical Gas Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.7.2 Romania Medical Gas Market Estimates and Forecasts, By Structure (2020-2032) (USD Billion)
10.3.1.7.3 Romania Medical Gas Market Estimates and Forecasts, By End-Use (2020-2032) (USD Billion)
10.3.1.8 Hungary
10.3.1.8.1 Hungary Medical Gas Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.8.2 Hungary Medical Gas Market Estimates and Forecasts, By Structure (2020-2032) (USD Billion)
10.3.1.8.3 Hungary Medical Gas Market Estimates and Forecasts, By End-Use (2020-2032) (USD Billion)
10.3.1.9 Turkey
10.3.1.9.1 Turkey Medical Gas Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.9.2 Turkey Medical Gas Market Estimates and Forecasts, By Structure (2020-2032) (USD Billion)
10.3.1.9.3 Turkey Medical Gas Market Estimates and Forecasts, By End-Use (2020-2032) (USD Billion)
10.3.1.10 Rest of Eastern Europe
10.3.1.10.1 Rest of Eastern Europe Medical Gas Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.10.2 Rest of Eastern Europe Medical Gas Market Estimates and Forecasts, By Structure (2020-2032) (USD Billion)
10.3.1.10.3 Rest of Eastern Europe Medical Gas Market Estimates and Forecasts, By End-Use (2020-2032) (USD Billion)
10.3.2 Western Europe
10.3.2.1 Trends Analysis
10.3.2.2 Western Europe Medical Gas Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.3.2.3 Western Europe Medical Gas Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.4 Western Europe Medical Gas Market Estimates and Forecasts, By Structure (2020-2032) (USD Billion)
10.3.2.5 Western Europe Medical Gas Market Estimates and Forecasts, By End-Use (2020-2032) (USD Billion)
10.3.2.6 Germany
10.3.2.6.1 Germany Medical Gas Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.6.2 Germany Medical Gas Market Estimates and Forecasts, By Structure (2020-2032) (USD Billion)
10.3.2.6.3 Germany Medical Gas Market Estimates and Forecasts, By End-Use (2020-2032) (USD Billion)
10.3.2.7 France
10.3.2.7.1 France Medical Gas Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.7.2 France Medical Gas Market Estimates and Forecasts, By Structure (2020-2032) (USD Billion)
10.3.2.7.3 France Medical Gas Market Estimates and Forecasts, By End-Use (2020-2032) (USD Billion)
10.3.2.8 UK
10.3.2.8.1 UK Medical Gas Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.8.2 UK Medical Gas Market Estimates and Forecasts, By Structure (2020-2032) (USD Billion)
10.3.2.8.3 UK Medical Gas Market Estimates and Forecasts, By End-Use (2020-2032) (USD Billion)
10.3.2.9 Italy
10.3.2.9.1 Italy Medical Gas Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.9.2 Italy Medical Gas Market Estimates and Forecasts, By Structure (2020-2032) (USD Billion)
10.3.2.9.3 Italy Medical Gas Market Estimates and Forecasts, By End-Use (2020-2032) (USD Billion)
10.3.2.10 Spain
10.3.2.10.1 Spain Medical Gas Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.10.2 Spain Medical Gas Market Estimates and Forecasts, By Structure (2020-2032) (USD Billion)
10.3.2.10.3 Spain Medical Gas Market Estimates and Forecasts, By End-Use (2020-2032) (USD Billion)
10.3.2.11 Netherlands
10.3.2.11.1 Netherlands Medical Gas Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.11.2 Netherlands Medical Gas Market Estimates and Forecasts, By Structure (2020-2032) (USD Billion)
10.3.2.11.3 Netherlands Medical Gas Market Estimates and Forecasts, By End-Use (2020-2032) (USD Billion)
10.3.2.12 Switzerland
10.3.2.12.1 Switzerland Medical Gas Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.12.2 Switzerland Medical Gas Market Estimates and Forecasts, By Structure (2020-2032) (USD Billion)
10.3.2.12.3 Switzerland Medical Gas Market Estimates and Forecasts, By End-Use (2020-2032) (USD Billion)
10.3.2.13 Austria
10.3.2.13.1 Austria Medical Gas Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.13.2 Austria Medical Gas Market Estimates and Forecasts, By Structure (2020-2032) (USD Billion)
10.3.2.13.3 Austria Medical Gas Market Estimates and Forecasts, By End-Use (2020-2032) (USD Billion)
10.3.2.14 Rest of Western Europe
10.3.2.14.1 Rest of Western Europe Medical Gas Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.14.2 Rest of Western Europe Medical Gas Market Estimates and Forecasts, By Structure (2020-2032) (USD Billion)
10.3.2.14.3 Rest of Western Europe Medical Gas Market Estimates and Forecasts, By End-Use (2020-2032) (USD Billion)
10.4 Asia Pacific
10.4.1 Trends Analysis
10.4.2 Asia Pacific Medical Gas Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.4.3 Asia Pacific Medical Gas Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.4 Asia Pacific Medical Gas Market Estimates and Forecasts, By Structure (2020-2032) (USD Billion)
10.4.5 Asia Pacific Medical Gas Market Estimates and Forecasts, By End-Use (2020-2032) (USD Billion)
10.4.6 China
10.4.6.1 China Medical Gas Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.6.2 China Medical Gas Market Estimates and Forecasts, By Structure (2020-2032) (USD Billion)
10.4.6.3 China Medical Gas Market Estimates and Forecasts, By End-Use (2020-2032) (USD Billion)
10.4.7 India
10.4.7.1 India Medical Gas Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.7.2 India Medical Gas Market Estimates and Forecasts, By Structure (2020-2032) (USD Billion)
10.4.7.3 India Medical Gas Market Estimates and Forecasts, By End-Use (2020-2032) (USD Billion)
10.4.8 Japan
10.4.8.1 Japan Medical Gas Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.8.2 Japan Medical Gas Market Estimates and Forecasts, By Structure (2020-2032) (USD Billion)
10.4.8.3 Japan Medical Gas Market Estimates and Forecasts, By End-Use (2020-2032) (USD Billion)
10.4.9 South Korea
10.4.9.1 South Korea Medical Gas Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.9.2 South Korea Medical Gas Market Estimates and Forecasts, By Structure (2020-2032) (USD Billion)
10.4.9.3 South Korea Medical Gas Market Estimates and Forecasts, By End-Use (2020-2032) (USD Billion)
10.4.10 Vietnam
10.4.10.1 Vietnam Medical Gas Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.10.2 Vietnam Medical Gas Market Estimates and Forecasts, By Structure (2020-2032) (USD Billion)
10.4.10.3 Vietnam Medical Gas Market Estimates and Forecasts, By End-Use (2020-2032) (USD Billion)
10.4.11 Singapore
10.4.11.1 Singapore Medical Gas Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.11.2 Singapore Medical Gas Market Estimates and Forecasts, By Structure (2020-2032) (USD Billion)
10.4.11.3 Singapore Medical Gas Market Estimates and Forecasts, By End-Use (2020-2032) (USD Billion)
10.4.12 Australia
10.4.12.1 Australia Medical Gas Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.12.2 Australia Medical Gas Market Estimates and Forecasts, By Structure (2020-2032) (USD Billion)
10.4.12.3 Australia Medical Gas Market Estimates and Forecasts, By End-Use (2020-2032) (USD Billion)
10.4.13 Rest of Asia Pacific
10.4.13.1 Rest of Asia Pacific Medical Gas Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.13.2 Rest of Asia Pacific Medical Gas Market Estimates and Forecasts, By Structure (2020-2032) (USD Billion)
10.4.13.3 Rest of Asia Pacific Medical Gas Market Estimates and Forecasts, By End-Use (2020-2032) (USD Billion)
10.5 Middle East and Africa
10.5.1 Middle East
10.5.1.1 Trends Analysis
10.5.1.2 Middle East Medical Gas Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.5.1.3 Middle East Medical Gas Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.4 Middle East Medical Gas Market Estimates and Forecasts, By Structure (2020-2032) (USD Billion)
10.5.1.5 Middle East Medical Gas Market Estimates and Forecasts, By End-Use (2020-2032) (USD Billion)
10.5.1.6 UAE
10.5.1.6.1 UAE Medical Gas Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.6.2 UAE Medical Gas Market Estimates and Forecasts, By Structure (2020-2032) (USD Billion)
10.5.1.6.3 UAE Medical Gas Market Estimates and Forecasts, By End-Use (2020-2032) (USD Billion)
10.5.1.7 Egypt
10.5.1.7.1 Egypt Medical Gas Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.7.2 Egypt Medical Gas Market Estimates and Forecasts, By Structure (2020-2032) (USD Billion)
10.5.1.7.3 Egypt Medical Gas Market Estimates and Forecasts, By End-Use (2020-2032) (USD Billion)
10.5.1.8 Saudi Arabia
10.5.1.8.1 Saudi Arabia Medical Gas Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.8.2 Saudi Arabia Medical Gas Market Estimates and Forecasts, By Structure (2020-2032) (USD Billion)
10.5.1.8.3 Saudi Arabia Medical Gas Market Estimates and Forecasts, By End-Use (2020-2032) (USD Billion)
10.5.1.9 Qatar
10.5.1.9.1 Qatar Medical Gas Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.9.2 Qatar Medical Gas Market Estimates and Forecasts, By Structure (2020-2032) (USD Billion)
10.5.1.9.3 Qatar Medical Gas Market Estimates and Forecasts, By End-Use (2020-2032) (USD Billion)
10.5.1.10 Rest of Middle East
10.5.1.10.1 Rest of Middle East Medical Gas Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.10.2 Rest of Middle East Medical Gas Market Estimates and Forecasts, By Structure (2020-2032) (USD Billion)
10.5.1.10.3 Rest of Middle East Medical Gas Market Estimates and Forecasts, By End-Use (2020-2032) (USD Billion)
10.5.2 Africa
10.5.2.1 Trends Analysis
10.5.2.2 Africa Medical Gas Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.5.2.3 Africa Medical Gas Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.2.4 Africa Medical Gas Market Estimates and Forecasts, By Structure (2020-2032) (USD Billion)
10.5.2.5 Africa Medical Gas Market Estimates and Forecasts, By End-Use (2020-2032) (USD Billion)
10.5.2.6 South Africa
10.5.2.6.1 South Africa Medical Gas Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.2.6.2 South Africa Medical Gas Market Estimates and Forecasts By Structure (2020-2032) (USD Billion)
10.5.2.6.3 South Africa Medical Gas Market Estimates and Forecasts, By End-Use (2020-2032) (USD Billion)
10.5.2.7 Nigeria
10.5.2.7.1 Nigeria Medical Gas Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.2.7.2 Nigeria Medical Gas Market Estimates and Forecasts, By Structure (2020-2032) (USD Billion)
10.5.2.7.3 Nigeria Medical Gas Market Estimates and Forecasts, By End-Use (2020-2032) (USD Billion)
10.5.2.8 Rest of Africa
10.5.2.8.1 Rest of Africa Medical Gas Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.2.8.2 Rest of Africa Medical Gas Market Estimates and Forecasts, By Structure (2020-2032) (USD Billion)
10.5.2.8.3 Rest of Africa Medical Gas Market Estimates and Forecasts, By End-Use (2020-2032) (USD Billion)
10.6 Latin America
10.6.1 Trends Analysis
10.6.2 Latin America Medical Gas Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.6.3 Latin America Medical Gas Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.6.4 Latin America Medical Gas Market Estimates and Forecasts, By Structure (2020-2032) (USD Billion)
10.6.5 Latin America Medical Gas Market Estimates and Forecasts, By End-Use (2020-2032) (USD Billion)
10.6.6 Brazil
10.6.6.1 Brazil Medical Gas Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.6.6.2 Brazil Medical Gas Market Estimates and Forecasts, By Structure (2020-2032) (USD Billion)
10.6.6.3 Brazil Medical Gas Market Estimates and Forecasts, By End-Use (2020-2032) (USD Billion)
10.6.7 Argentina
10.6.7.1 Argentina Medical Gas Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.6.7.2 Argentina Medical Gas Market Estimates and Forecasts, By Structure (2020-2032) (USD Billion)
10.6.7.3 Argentina Medical Gas Market Estimates and Forecasts, By End-Use (2020-2032) (USD Billion)
10.6.8 Colombia
10.6.8.1 Colombia Medical Gas Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.6.8.2 Colombia Medical Gas Market Estimates and Forecasts, By Structure (2020-2032) (USD Billion)
10.6.8.3 Colombia Medical Gas Market Estimates and Forecasts, By End-Use (2020-2032) (USD Billion)
10.6.9 Rest of Latin America
10.6.9.1 Rest of Latin America Medical Gas Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.6.9.2 Rest of Latin America Medical Gas Market Estimates and Forecasts, By Structure (2020-2032) (USD Billion)
10.6.9.3 Rest of Latin America Medical Gas Market Estimates and Forecasts, By End-Use (2020-2032) (USD Billion)
11. Company Profiles
11.1 Air Liquide
11.1.1 Company Overview
11.1.2 Financial
11.1.3 Product/ Services Offered
11.1.4 SWOT Analysis
11.2 Linde plc
11.2.1 Company Overview
11.2.2 Financial
11.2.3 Product/ Services Offered
11.2.4 SWOT Analysis
11.3 Praxair Technology Inc.
11.3.1 Company Overview
11.3.2 Financial
11.3.3 Product/ Services Offered
11.3.4 SWOT Analysis
11.4 Air Products and Chemicals Inc.
11.4.1 Company Overview
11.4.2 Financial
11.4.3 Product/ Services Offered
11.4.4 SWOT Analysis
11.5 Taiyo Nippon Sanso Corporation
11.5.1 Company Overview
11.5.2 Financial
11.5.3 Product/ Services Offered
11.5.4 SWOT Analysis
11.6 Atlas Copco AB
11.6.1 Company Overview
11.6.2 Financial
11.6.3 Product/ Services Offered
11.6.4 SWOT Analysis
11.7 SOL Group
11.7.1 Company Overview
11.7.2 Financial
11.7.3 Product/ Services Offered
11.7.4 SWOT Analysis
11.8 GCE Group
11.8.1 Company Overview
11.8.2 Financial
11.8.3 Product/ Services Offered
11.8.4 SWOT Analysis
11.9 Amico Corporation
11.9.1 Company Overview
11.9.2 Financial
11.9.3 Product/ Services Offered
11.9.4 SWOT Analysis
11.10 Matheson Tri-Gas Inc.
11.10.1 Company Overview
11.10.2 Financial
11.10.3 Product/ Services Offered
11.10.4 SWOT Analysis
12. Use Cases and Best Practices
13. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
By Product
Pure Gases
Medical Air
Oxygen
Carbon Dioxide
Nitrous Oxide
Nitrogen
Helium
Gas Mixtures
Aerobic Gas Mixtures
Anaerobic Gas Mixtures
Medical Laser Mixtures
Blood Gas Mixtures
Lung Diffusion Mixtures
Medical Drug Gas Mixtures
Other Gas Mixtures
By End Use
Hospitals
Ambulatory Surgical Centers
Home Healthcare
Pharmaceutical And Biotechnology Companies
Diagnostic and Research Laboratories
Academic and Research Institutions
By Application
Therapeutic
Diagnostic
Pharmaceutical Manufacturing
Others
Request for Segment Customization as per your Business Requirement: Segment Customization Request
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Detailed Volume Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Competitive Product Benchmarking
Geographic Analysis
Additional countries in any of the regions
Customized Data Representation
Detailed analysis and profiling of additional market players
Bladder Cancer Detection Kit Market was valued at USD 1.63 billion in 2023 and is expected to reach USD 2.99 billion by 2032, growing at a CAGR of 7.04%.
The Medical Billing Market was valued at USD 15.43 billion in 2023 and is expected to reach USD 41.32 billion by 2032, growing at a CAGR of 11.58% over the forecast period 2024-2032.
The Biopreservation Market size was estimated at USD 3.5 billion in 2023 and is expected to reach USD 14.3 billion by 2032 at a CAGR of 17.0% during the forecast period of 2024-2032.
The Clinical Alarm Management Market Size was valued at USD 2.42 billion in 2023 and is expected to reach USD 9.02 billion by 2032 and grow at a CAGR of 15.75%.
The Scoliosis Management Market size was USD 3060.51 Million in 2023 and is expected to Reach USD 4356.06 Million by 2032 and grow at a CAGR of 4% over the forecast period of 2024-2032.
The Artificial Cornea and Corneal Implant Market was valued at USD 478.73 million in 2023 and is expected to reach USD 910.85 million by 2032, growing at a CAGR of 7.45% from 2024-2032.
Hi! Click one of our member below to chat on Phone
© 2025 All Rights Reserved by SNS Insider Pvt Ltd
